Dietary levels of quinine in tonic water do not inhibit CYP2D6 in vivo

This publication has 10 references indexed in Scilit:

• EFFECTIVENESS OF QUININE IN TREATING MUSCLE CRAMPS: A DOUBLE‐BLIND, PLACEBO‐CONTROLLED, PARALLEL‐GROUP, MULTICENTRE TRIAL
  International Journal Of Clinical Practice, 2002
• Differential Time Course of Cytochrome P450 2D6 Enzyme Inhibition by Fluoxetine, Sertraline, and Paroxetine in Healthy Volunteers
  Journal of Clinical Psychopharmacology, 2002
• Effect of St. John's wort (Hypericum perforatum) on cytochrome P-450 2D6 and 3A4 activity in healthy volunteers
  Life Sciences, 2000
• Should People with Nocturnal Leg Cramps Drink Tonic Water and Bitter Lemon?
  Psychological Reports, 1999
• Modified high-performance liquid chromatographic method to measure both dextromethorphan and proguanil for oxidative phenotyping
  Journal of Chromatography B: Biomedical Sciences and Applications, 1997
• The role of cytochrome P4502D6 in the metabolism of paroxetine by human liver microsomes.
  British Journal of Clinical Pharmacology, 1992
• Quinine is a more potent inhibitor than quinidine in rat of the oxidative metabolic routes of methoxyphenamine which involve debrisoquine 4-hydroxylase
  Xenobiotica, 1991
• Quinidine but not quinine inhibits in man the oxidative metabolic routes of methoxyphenamine which involve debrisoquine 4-hydroxylase
  European Journal of Clinical Pharmacology, 1991
• The specificity of inhibition of debrisoquine 4-hydroxylase activity by quinidine and quinine in the rat is the inverse of that in man
  Biochemical Pharmacology, 1989
• Inhibition of desipramine 2-hydroxylation by quinidine and quinine
  Clinical Pharmacology & Therapeutics, 1988